Monthly Archives: August 2013
A research team has identified a cell signaling pathway which plays a significant role in causing developmental defects of the fetal spinal cord and brain in babies of women with diabetes.
Scientists have identified a previously unknown genetic variant associated with an increased risk of coronary heart disease (CHD) in type 2 diabetic patients.
The study found that both treatments induced positive changes in the level of particles that carry cholesterol and triglycerides through the blood stream.
Researchers have created the first risk score that predicts the 10-year individualized dementia risk for patients with type 2 diabetes.
Glucagon, a hormone involved in regulating appetite, loses its ability to help obese people feel full after a meal, but it continues to suppress hunger pangs in people with type 1 diabetes, according to a recent study.
Blocking dietary sugar and its activity in tumor cells may reduce cancer risk and progression, according to researchers.
People who walk to work are around 40% less likely to have diabetes as those who drive, according to a new study.
A study has found that higher blood sugar levels are associated with higher dementia risk, even among people who do not have diabetes.
An experimental drug designed to block the advance of type 1 diabetes in its earliest stages has proven strikingly effective over two years in about half of the patients who participated in the phase 2 clinical trial.
Eating a healthy diet and drinking a moderate amount of alcohol may be associated with decreased risk or progression of chronic kidney disease (CKD) in patients with type 2 diabetes mellitus.
The FDA is working with Nova Diabetes Care to recall 21 lots of glucose test strips marketed under the brand names Nova Max Blood Glucose Test Strips and Nova Max Plus Glucose Meter Kits. The test strips under recall may report a false, abnormally high blood glucose result.